Guidance for manufacturers of IVC filters. It outlines specific scenarios that should be considered when determining if an incident is reportable.
Similar Posts
Form: Decentralised Manufacture: The designation step application form
Application Form to be completed by an Applicant and sent to the MHRA requesting consideration of an award of a Decentralised Manufacture (DM) Designation.
Statutory guidance: MHRA fees
Fees payable to the MHRA from 2025.
Guidance: Innovative Licensing and Access Pathway (ILAP)
The Innovative Licensing and Access Pathway (ILAP) is focused on getting the most transformative new medicines to patients in the UK health system more quickly.
Field Safety Notices: 10 to 14 November 2025
List of Field Safety Notices from 10 to 14 November 2025.
MHRA Safety Roundup: May 2025
Summary of the latest safety advice for medicines and medical device users
Decision: Parallel import licences granted in 2025
Parallel import licences granted in 2025.